Exact Sciences (EXAS) Tops Q3 EPS by 27c, provides guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of $0.24, $0.27 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $851 million versus the consensus estimate of $810.36 million.
GUIDANCE:
Exact Sciences sees FY2025 revenue of $3.22-3.235 billion, versus the consensus of $3.157 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Li Ning Co. Ltd. (2331:HK) (LNNGF) to Neutral
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Oppenheimer Reiterates Outperform Rating on Kyntra Bio (KYNB)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
